咳止めシロップの世界市場2026

Market Research Futureが発行した調査報告書(MRF9DC024)
◆英語タイトル:Global Cough Syrup Market Research Report Forecast to 2026
◆商品コード:MRF9DC024
◆発行会社(リサーチ会社):Market Research Future
◆発行日:2019年10月
◆ページ数:124
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Online Access)USD4,450 ⇒換算¥480,600見積依頼/購入/質問フォーム
Enterprisewide Price(印刷可)USD6,250 ⇒換算¥675,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Research Future社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Market Research Future社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、咳止めシロップの世界市場について調査・分析し、エグゼクティブサマリー、市場紹介、調査方法、市場動向、市場要因分析、カテゴリー別(咳抑制剤、去痰(たん))分析、製品タイプ別(デキストロメトルファン、グアイフェネシン、アンブロキソール、フェニレフリン、アセトアミノフェン、ジフェンヒドラミン、フォルコジン、プソイドエフェドリン、コデイン、併用薬、その他)分析、用途別(大人用、子供用)分析、地域別分析、競合分析、会社概要などを含め、以下の構成でお届けします。
・エグゼクティブサマリー
・市場紹介
・調査方法
・市場動向
・市場要因分析
・咳止めシロップの世界市場:カテゴリー別(咳抑制剤、去痰(たん))
・咳止めシロップの世界市場:製品タイプ別(デキストロメトルファン、グアイフェネシン、アンブロキソール、フェニレフリン、アセトアミノフェン、ジフェンヒドラミン、フォルコジン、プソイドエフェドリン、コデイン、併用薬、その他)
・咳止めシロップの世界市場:用途別(大人用、子供用)
・咳止めシロップの世界市場:地域別分析
・競合分析
・会社概要
【レポートの概要】

Global Cough Syrup Market: Information by Product Type (Combination {Dextromethorphan + Guaifenesin, Guaifenesin + Pseudoephedrine and Brompheniramine + Pseudoephedrine} and Individual {Dextromethorphan, Guaifenesin, Ambroxol and Codeine}), by Category (Cough Suppressants and Expectorants), by Application (Adults and Children) and by Region ( Americas, Europe, Asia-Pacific, Middle East & Africa) – Forecast till 2026

Market analysis
Nowadays, intensifying air contamination is appearing as a driver for the growth of the market. Air pollution is a major environment-related health threat that stands as a risk component for both acute and chronic respiratory illnesses. Concurring to a report by the Forum of International Respiratory Societies (FIRS), tobacco smoke, indoor air pollution from burning fuels, and air pollution from traffic and industrial sources are highlighted as the primary contributing factors for most respiratory circumstances. During February 2019, Merck invested USD 70 million to expand its research & development (R&D) facility in Billerica, Massachusetts for the development of innovative clinical pipeline products. World Health Organization (WHO) estimated that 4.3 million deaths per year could be ascribed to indoor air pollution. Most diseases and deaths that can be attributed to protracted exposure to poor indoor air quality occurs primarily in women and children, especially in low-income families. Exposure to indoor smoke used for heating and cooking leads to COPD, lung cancer, and, in children, it causes pneumonia and asthma. This sizable population involved with respiratory ailments due to air pollution is pushing the market for cough syrup market as it is a crucial medicine used for the therapy of such diseases. The increasing incidence of respiratory disorders along with the rising air pollution are some of the key factors supporting to the growth of the cough syrup market. Additionally, the expanding geriatric population, along with an active pharmaceutical sector, are boosting market growth as aged people are more prone to respiratory disorders. Furthermore, the market is expected to corroborate lucrative growth owing to ever-increasing product improvements.

Market segmentation
The Global cough syrup market has been segmented by type, application product type, category, application and by region. The individual product type has been beyond apportioned into dextromethorphan, guaifenesin, ambroxol, and codeine. In December 2016, it was noted that Pfizer, Inc., launched a series of products as a line expansion under the Corex brand name. The first launch was on December 2016, and following releases were conducted in 2017. These designs were duly endorsed by central and state regulators. Based on the category, the market has been segmented into cough suppressants and cough syrup. And by application, the cough syrup market has been classified as adults and children. Then in July 2018, Johnson & Johnson acquired Zarbee’s Naturals, a drug-free children’s cough syrup. The Americas is projected to hold a full share of the global cough syrup market, and the regional market is forecasted to register a CAGR of 3.16% during the forecast period. The presence of significant market players in the region, strategic acquisitions by major players to augment product selection, cumulative cases of respiratory disorders, and availability of advanced medications for the treatment of chronic obstructive pulmonary disease (COPD) is expected to drive the market development in this region to battle these concerns effectively through the use of cough syrups. This enabled the company to expand its product portfolio globally. Combination product type has been further categorized as dextromethorphan + guaifenesin, guaifenesin + pseudoephedrine, and brompheniramine + pseudoephedrine. Based on product type, the market has been isolated into combination and entities.

Regional analysis
Geographically, Global cough syrup market is split in regions like North & Latin America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. The Middle East & Africa cough syrup market has been segmented into major two regions, the Middle East and Africa. The established nations in the region, such as the UAE and Saudi Arabia, are the ones with the highest share of the cough syrup market. The advancing healthcare transportation, expanding healthcare expenditure, and increasing per capita disposable incomes of the people in these countries are some reasons leading to the large share of the market in these countries. Africa is the minimum built region with limited healthcare resources and services for the people. The low growth rate due to less created and less efficient health systems is hampering the growth of the market. Asia-Pacific is estimated to be the fastest-growing market due to the constant development in emerging countries such as India and China. High occurrence of respiratory disorders due to tobacco smoke, experience to air pollutants at home and the workplace, vehicular pollution, and indoor air pollution from biological agents related to moist and mold additional upsurge the risk of respiratory disease in children and adults in these nations. Europe accounts for the second largest, in the global cough syrup market, majorly due to the presence of key players such as Novartis, GlaxoSmithKline, and Reckitt Benckiser Group PLC. The cough syrup market in Europe is likely to be propelled by the expansion of the pharmaceutical business in Germany, France, and the UK.

Major players
The proposed spectators in the Global cough syrup market are cough syrup manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global cough syrup market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global cough syrup market are companies like Acella Pharmaceuticals, LLC (US), Pfizer, Inc. (US), Novartis AG (Switzerland), Merck KGaA (US), GlaxoSmithKline PLC (UK), Procter & Gamble (US), Reckitt Benckiser Group PLC (UK), Abbott (US), Sanofi (France) and Johnson & Johnson Services, Inc. (US).

【レポートの目次】

Table of Contents:

1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Market Structure
2.4 Development of cough syrup
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising Prevalence of Chronic Respiratory Disease
4.2.2 Increasing Geriatric Population
4.2.3 Rising Air Pollution
4.3 Restraints
4.3.1 Stringent Regulatory Framework
4.3.2 Product Recall
4.4 Opportunity
4.4.1 Entering Developing Economies
4.5 Macroeconomics
5 Market Factor Analysis
5.1 Supply/Value Chain Analysis
5.1.1 Raw Material Procurement
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 End Users
5.2 Porter’s Five Forces Model
5.2.1 Threat of New Entrants
5.2.2 Bargaining Power of Suppliers
5.2.3 Bargaining Power of Buyers
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Cough Syrup Cost of Production Analysis
5.3.1 Cost Overview
5.3.2 Raw Material Cost Analysis
5.3.3 Labor Cost Analysis
5.4 Manufacturers by Region
5.4.1 Americas
5.4.2 Europe
5.4.3 Asia Pacific
5.4.4 Middle East & Africa
5.5 Plant Locations
6 Global Cough Syrup Market, by Category
6.1 Introduction
6.2 Cough Suppressants
6.3 Expectorants
7 Global Cough Syrup Market, by Product Type
7.1 Introduction
7.2 Americas
7.2.1 Dextromethorphan
7.2.2 Guaifenesin
7.2.3 Ambroxol
7.2.4 Phenylephrine
7.2.5 Acetaminophen
7.2.6 Diphenhydramine
7.2.7 Pholcodine
7.2.8 Pseudoephedrine
7.2.9 Codeine
7.2.10 Combination Drugs
7.2.11 Others
7.3 Europe
7.3.1 Dextromethorphan
7.3.2 Guaifenesin
7.3.3 Ambroxol
7.3.4 Phenylephrine
7.3.5 Acetaminophen
7.3.6 Diphenhydramine
7.3.7 Pholcodine
7.3.8 Pseudoephedrine
7.3.9 Codeine
7.3.10 Combination Drugs
7.3.11 Others
7.4 Asia-Pacific
7.4.1 Chlorpheniramine + Codeine
7.4.2 Levosalbutamol + Ambroxol + Guaifenesin
7.4.3 Phenylephrine + CPM + Dextromethorphan
7.4.4 Chlorpheniramine + Dextromethorphan
7.4.5 Paracetamol + Phenylephrine + Chlorpheniramine
7.4.6 Guaifenesin + Terbutaline + Bromhexine
7.4.7 Guaifenesin + Terbutaline + Ambroxol
7.4.8 Phenylephrine + Chlorpheniramine
7.4.9 Ammonium + CPM + Dextromethorphan + Guaifenesin
7.4.10 Bromhexine + Dextromethorphan + Ammonium Chloride
7.4.11 Individual Drug
7.4.12 Others
7.5 Middle East & Africa
7.5.1 Dextromethorphan + Guaifenesin
7.5.2 Dextromethorphan + Diphenhydramine Hydrochloride + Pseudoephedrine
7.5.3 Guaifenesin + Pseudoephedrine
7.5.4 Chlorpheniramine Maleate + Paracetamol + Pseudoephedrine
7.5.5 Chlorpheniramine + Phenylepherine
7.5.6 Brompheniramine + Pseudoephedrine
7.5.7 Pseudoephedrine + Triprolidin
7.5.8 Carbenoxamine + Pseudoephedrine
7.5.9 Loratadine + Pseudoephedrine
7.5.10 Individual Drugs
7.5.11 Others
8 Global Cough Syrup Market, by Application
8.1 Introduction
8.2 Adults
8.3 Children
9 Global Cough syrup Market, by Region
9.1 Overview
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Russia
9.3.7 Benelux
9.3.8 Poland
9.3.9 Romania
9.3.10 Rest of Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South East Asia
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.1.1 Saudi Arabia
9.5.1.2 Egypt
9.5.1.3 Rest of Middle East
9.5.2 Africa
9.5.2.1 Algeria
9.5.2.2 Sudan
9.5.2.3 Morocco
9.5.2.4 Libya
9.5.2.5 Tunisia
9.5.2.6 Rest of Africa
10 Competitive Landscape
10.1 Introduction
10.2 Key Developments & Growth Strategies
10.2.1 Mergers & Acquisitions
10.2.2 Agreements
10.3 Expansion
10.4 Product Launch
11 Company Profile
11.1 Pfizer, Inc.
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products/Services Offered
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.1.6 Key Strategies
11.2 Novartis AG
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products/Services Offered
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategies
11.3 Merck KGaA
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products/Services Offered
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.3.6 Key Strategies
11.4 Johnson & Johnson Services, Inc.
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products/Services Offered
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategies
11.5 GlaxoSmithKline PLC
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products/Services Offered
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.5.6 Key Strategies
11.6 Acella Pharmaceuticals, LLC
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products/Services Offered
11.6.4 SWOT Analysis
11.6.5 Key Strategies
11.7 Procter & Gamble
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products/Services Offered
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategies
11.8 Reckitt Benckiser Group PLC
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products/Services Offered
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8.6 Key Strategies
11.9 Abbott
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products/Services Offered
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategies
11.1 Sanofi
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products/Services Offered
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategies
12 Appendix
12.1 References
12.2 Related Reports

List of Tables:

TABLE 1 MARKET SYNOPSIS
TABLE 2 COUGH SYRUP COST OF PRODUCTION ANALYSIS
TABLE 3 GLOBAL COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 4 GLOBAL COUGH SYRUP MARKET FOR COUGH SUPPRESSANTS, BY REGION, 2014–2026 (USD MILLION)
TABLE 5 GLOBAL COUGH SYRUP MARKET FOR EXPECTORANTS, BY REGION, 2014–2026 (USD MILLION)
TABLE 6 AMERICAS COUGH SYRUP MARKET BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 7 EUROPE COUGH SYRUP MARKET BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 8 ASIA-PACIFIC COUGH SYRUP MARKET BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA COUGH SYRUP MARKET BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 10 GLOBAL COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 11 GLOBAL COUGH SYRUP MARKET FOR ADULTS, BY REGION, 2014–2026 (USD MILLION)
TABLE 12 GLOBAL COUGH SYRUP MARKET FOR CHILDREN, BY REGION, 2014–2026 (USD MILLION)
TABLE 13 GLOBAL COUGH SYRUP MARKET, BY REGION, 2014–2026 (USD MILLION)
TABLE 14 GLOBAL COUGH SYRUP MARKET VOLUME, BY REGION, 2014–2S018 (UNIT)
TABLE 15 AMERICAS: COUGH SYRUP MARKET, BY REGION, 2014–2026 (USD MILLION)
TABLE 16 AMERICAS: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 17 AMERICAS: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 18 AMERICAS: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 19 NORTH AMERICA: COUGH SYRUP MARKET, BY COUNTRY, 2014–2026 (USD MILLION)
TABLE 20 NORTH AMERICA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 21 NORTH AMERICA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 22 NORTH AMERICA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 23 US: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 24 US: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 25 US: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 26 CANADA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 27 CANADA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 28 CANADA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 29 SOUTH AMERICA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 30 SOUTH AMERICA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 31 SOUTH AMERICA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 32 GERMANY: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 33 GERMANY: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 34 GERMANY: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 35 FRANCE: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 36 FRANCE: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 37 FRANCE: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 38 UK: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 39 UK: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 40 UK: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 41 ITALY: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 42 ITALY: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 43 ITALY: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 44 SPAIN: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 45 SPAIN: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 46 SPAIN: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 47 RUSSIA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 48 RUSSIA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 49 RUSSIA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 50 BENELUX: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 51 BENELUX: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 52 BENELUX: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 53 POLAND: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 54 POLAND:: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 55 POLAND:: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 56 ROMANIA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 57 ROMANIA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 58 ROMANIA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 59 REST OF EUROPE: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 60 REST OF EUROPE: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 61 REST OF EUROPE: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 62 ASIA PACIFIC: COUGH SYRUP MARKET, BY COUNTRY, 2014–2026 (USD MILLION)
TABLE 63 ASIA PACIFIC: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 64 ASIA PACIFIC: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 65 ASIA PACIFIC: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 66 CHINA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 67 CHINA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 68 CHINA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 69 JAPAN: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 70 JAPAN: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 71 JAPAN: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 72 INDIA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 73 INDIA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 74 INDIA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 75 AUSTRALIA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 76 AUSTRALIA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 77 AUSTRALIA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 78 SOUTH EAST ASIA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 79 SOUTH EAST ASIA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 80 SOUTH EAST ASIA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 81 REST OF ASIA PACIFIC: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 82 REST OF ASIA PACIFIC: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 83 REST OF ASIA PACIFIC: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 84 MIDDLE EAST & AFRICA: COUGH SYRUP MARKET, BY REGION, 2014–2026 (USD MILLION)
TABLE 85 MIDDLE EAST & AFRICA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 86 MIDDLE EAST & AFRICA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 87 MIDDLE EAST & AFRICA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 88 MIDDLE EAST: COUGH SYRUP MARKET, BY COUNTRY, 2014–2026 (USD MILLION)
TABLE 89 MIDDLE EAST: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 90 MIDDLE EAST: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 91 MIDDLE EAST: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 92 SAUDI ARABIA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 93 SAUDI ARABIA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 94 SAUDI ARABIA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 95 EGYPT: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 96 EGYPT: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 97 EGYPT: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 98 REST OF MIDDLE EAST: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 99 REST OF MIDDLE EAST: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 100 REST OF MIDDLE EAST: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 101 AFRICA: COUGH SYRUP MARKET, BY COUNTRY, 2014–2026 (USD MILLION)
TABLE 102 AFRICA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 103 AFRICA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 104 AFRICA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 105 ALGERIA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 106 ALGERIA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 107 ALGERIA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 108 SUDAN: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 109 SUDAN: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 110 SUDAN: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 111 MOROCCO: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 112 MOROCCO: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 113 MOROCCO: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 114 LIBYA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 115 LIBYA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 116 LIBYA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 117 TUNISIA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 118 TUNISIA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 119 TUNISIA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 120 REST OF AFRICA: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
TABLE 121 REST OF AFRICA: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
TABLE 122 REST OF AFRICA: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
TABLE 123 MERGERS & ACQUISITIONS
TABLE 124 AGREEMENTS
TABLE 125 EXPANSION
TABLE 126 PRODUCT LAUNCH

List of Figures:

FIGURE 1 GLOBAL COUGH SYRUP MARKET: MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS OF MRFR
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL COUGH SYRUP MARKET
FIGURE 5 SUPPLY/VALUE CHAIN: GLOBAL COUGH SYRUP MARKET
FIGURE 6 MANUFACTURING PROCESS
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL COUGH SYRUP MARKET
FIGURE 8 GLOBAL COUGH SYRUP MARKET, BY CATEGORY, 2018 & 2026 (USD MILLION)
FIGURE 9 AMERICAS COUGH SYRUP MARKET, BY PRODUCT TYPE, 2018 & 2026 (USD MILLION)
FIGURE 10 EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2018 & 2026 (USD MILLION)
FIGURE 11 ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, 2018 & 2026 (USD MILLION)
FIGURE 12 MIDDLE EAST & AFRICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2018 & 2026 (USD MILLION)
FIGURE 13 GLOBAL COUGH SYRUP MARKET, BY APPLICATION, 2018 & 2026 (USD MILLION)
FIGURE 14 GLOBAL COUGH SYRUP MARKET, BY REGION, 2018 (%)
FIGURE 15 AMERICAS: COUGH SYRUP MARKET SHARE, BY REGION, 2018 (%)
FIGURE 16 NORTH AMERICA: COUGH SYRUP MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 17 EUROPE: COUGH SYRUP MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 18 EUROPE: COUGH SYRUP MARKET, BY COUNTRY, 2014–2026 (USD MILLION)
FIGURE 19 EUROPE: COUGH SYRUP MARKET, BY CATEGORY, 2014–2026 (USD MILLION)
FIGURE 20 EUROPE: COUGH SYRUP MARKET, BY PRODUCT TYPE, 2014–2026 (USD MILLION)
FIGURE 21 EUROPE: COUGH SYRUP MARKET, BY APPLICATION, 2014–2026 (USD MILLION)
FIGURE 22 ASIA-PACIFIC: COUGH SYRUP MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 23 MIDDLE EAST & AFRICA: COUGH SYRUP MARKET SHARE, BY REGION, 2018 (%)
FIGURE 24 COMPANY MARKET SHARE ANALYSIS, 2018 (%)

【掲載企業】

Acella Pharmaceuticals, LLC (US), Pfizer, Inc. (US), Novartis AG (Switzerland), Merck KGaA (US), GlaxoSmithKline PLC (UK), Procter & Gamble (US), Reckitt Benckiser Group PLC (UK), Abbott (US), Sanofi (France) and Johnson & Johnson Services, Inc. (US)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 咳止めシロップの世界市場2026(Global Cough Syrup Market Research Report Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆